Advance Nanotech Named as a Key Player in Nanotechnology Industry by Leading Analyst Firm
|Report by Griffin Securities Highlights the Potential of Nanotechnology to Impact All Industries|
“We believe this rating reflects the strength of our business model as well as our continued dedication to bridging the gap between innovation and solutions for high-value markets.”
Advance Nanotech, Inc., (OTC BB:AVNA.OB - News), the premier provider of financing and support services to drive the commercialization of nanotechnology discoveries, today announced that it has been cited in a recent report by Griffin Securities entitled "Nanotechnology Industry Review, An Overview of Companies in the Nanotechnology Space." To obtain a copy of the report, please contact Griffin Securities (www.griffinsecurities.com) at (212) 509-9500 or firstname.lastname@example.org.
"We believe nanotechnology will be one of the next great technology revolutions and nanotechnology's impact will be felt broadly throughout all industries. Nanotechnology is already producing real products, and we believe more are on the way," according to the report. The report also points out that government investment in nanotechnology research, facilities and business incubation programs has made "nanotechnology the largest publicly funded science initiative since the space race. Numerous products, from cellphone battery boosters to tennis racquets, are made with nanotechnology. In fact, there is not a single industry that is either now, or eventually will not be, dramatically changed by nanotechnological applications."
Advance Nanotech is currently funding 21 portfolio companies in the electronics, biopharma, and materials industries. The firm provides services ranging from funding, to human capital and research equipment essential to ensuring that the most promising companies can accelerate the path to rapid commercialization. In this way, investor exposure to any particular technology is mitigated with Advance Nanotech retaining the option to increase investment in those technologies that successfully mature.
"We are very pleased to be recognized by Griffin as a leader in the development of new nanotechnology products," said Magnus Gittins, CEO of Advance Nanotech. "We believe this rating reflects the strength of our business model as well as our continued dedication to bridging the gap between innovation and solutions for high-value markets."
About Advance Nanotech, Inc.
Advance Nanotech Inc. is dedicated to ensuring nanotechnology discoveries reach maximum market potential through successful commercialization. Advance is the trusted guide to commercial success for nanotech entrepreneurs spanning the globe, partnering with leading universities to provide scientists and researchers with mission critical infrastructure support to transform their discoveries to marketable solutions. The organization provides a range of services and support including financing, leadership assets and counsel on intellectual property, licensing and regulatory issues. With a portfolio of 21 companies developing technologies which offer potentially breakthrough nanotechnology discoveries in the electronics, biopharma and materials sectors, Advance's goal is to transform the potential for nanotechnology discoveries into innovative products that further evolve existing industries and enable new markets.
# # #
This document contains forward-looking statements by Advance Nanotech regarding its expectations as to its business, and involves risks and uncertainties and may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements.
Factors that may cause such a difference include, but are not limited to, problems and risks associated with developments in the nanotechnology industry in general and in Advance Nanotech's products under development in particular; the potential failure of Advance Nanotech's products under development to prove safe and effective in application; uncertainties inherent in the early stage of Advance Nanotech's products under development; failure to successfully implement or complete research programmes; failure to receive marketing clearance from regulatory agencies for our products under development; acquisitions, divestitures, mergers, licenses or strategic initiatives that change Advance Nanotech's business, structure or projections; the development of competing products; uncertainties related to Advance Nanotech 's dependence on third parties and partners; and those risks described Advance Nanotech 's filings with the SEC. Advance Nanotech disclaims any obligation to update these forward-looking statements.
Further information about these and other relevant risks and uncertainties may be found in the Advance Nanotech's findings with the Securities and Exchange Commission, all of which are available from the Commission as well as other sources.